Navigating Late Line R/R Multiple Myeloma: Treatment Landscape, Patient Care, and Quality of Life - Episode 2

Challenges in Managing Late-Line RRMM

March 24, 2025
Saad Usmani, MD

,
Amrita Krishnan, MD

Panelists discuss how the term “late-line” emerged organically in clinical practice to describe patients who had exhausted multiple treatment options, with most experts recalling its growing usage over the past decade as novel therapies expanded the treatment landscape and created a need to distinguish between patients with early and more heavily pretreated relapsed/refractory multiple myeloma (R/R MM).

Video content above is prompted by the following:

  • When did you first hear the term “late-line,” and how was it explained to you?